MD4458C1 - Utilizarea preparatului Polibiolină în tratamentul bolnavilor cu ciroză hepatică - Google Patents

Utilizarea preparatului Polibiolină în tratamentul bolnavilor cu ciroză hepatică

Info

Publication number
MD4458C1
MD4458C1 MDA20150017A MD20150017A MD4458C1 MD 4458 C1 MD4458 C1 MD 4458C1 MD A20150017 A MDA20150017 A MD A20150017A MD 20150017 A MD20150017 A MD 20150017A MD 4458 C1 MD4458 C1 MD 4458C1
Authority
MD
Moldova
Prior art keywords
drug
polybiolin
patients
liver cirrhosis
dose
Prior art date
Application number
MDA20150017A
Other languages
English (en)
Russian (ru)
Other versions
MD20150017A2 (ro
MD4458B1 (ro
Inventor
Мария ДАНУ
Галина ПАВЛЮК
Original Assignee
Мария ДАНУ
Галина ПАВЛЮК
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мария ДАНУ, Галина ПАВЛЮК filed Critical Мария ДАНУ
Priority to MDA20150017A priority Critical patent/MD4458C1/ro
Publication of MD20150017A2 publication Critical patent/MD20150017A2/ro
Publication of MD4458B1 publication Critical patent/MD4458B1/ro
Publication of MD4458C1 publication Critical patent/MD4458C1/ro

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Invenţia se referă la medicină, şi anume la utilizarea preparatului Polibiolină la pacienţii cu ciroză hepatică, totodată preparatul se administrează intramuscular, în doză de 500 mg, în decurs de 8…10 zile.
MDA20150017A 2014-06-19 2014-06-19 Utilizarea preparatului Polibiolină în tratamentul bolnavilor cu ciroză hepatică MD4458C1 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20150017A MD4458C1 (ro) 2014-06-19 2014-06-19 Utilizarea preparatului Polibiolină în tratamentul bolnavilor cu ciroză hepatică

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20150017A MD4458C1 (ro) 2014-06-19 2014-06-19 Utilizarea preparatului Polibiolină în tratamentul bolnavilor cu ciroză hepatică

Publications (3)

Publication Number Publication Date
MD20150017A2 MD20150017A2 (ro) 2016-04-30
MD4458B1 MD4458B1 (ro) 2017-01-31
MD4458C1 true MD4458C1 (ro) 2017-08-31

Family

ID=55911138

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20150017A MD4458C1 (ro) 2014-06-19 2014-06-19 Utilizarea preparatului Polibiolină în tratamentul bolnavilor cu ciroză hepatică

Country Status (1)

Country Link
MD (1) MD4458C1 (ro)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0827742A1 (en) * 1996-09-04 1998-03-11 Vrije Universiteit Brussel Use of histone deacetylase inhibitors for treating fribosis or cirrhosis
MD1780F1 (ro) * 2001-02-02 2001-11-30 Univ Nicolae Testemitanu Metoda de tratament al pacientilor cu ciroze hepatice
DE102005025906A1 (de) * 2005-06-06 2006-12-07 Dorian Bevec Therapeutischer Gebrauch aromatischer Guanylhydrazone zur Behandlung von Hepatitis C Virus-verursachten Erkrankungen
DE102005059750A1 (de) * 2005-12-09 2007-06-14 Salama, Zoser Boulis, Dr. Antikrebsmittel umfassend Arsen-Verbindungen
WO2011061454A1 (fr) * 2009-11-20 2011-05-26 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Utilisation d'immunoglobulines polyvalentes pour traiter une cirrhose hepatique alcoolique ou metabolique
MD4317B1 (en) * 2013-09-12 2015-01-31 Gheorghe Anghelici Use of 3-(2,2,2-trimethylhydrazinium)propionate dihydrate for treating patients with advanced liver cirrhosis associated with heart failure

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0827742A1 (en) * 1996-09-04 1998-03-11 Vrije Universiteit Brussel Use of histone deacetylase inhibitors for treating fribosis or cirrhosis
MD1780F1 (ro) * 2001-02-02 2001-11-30 Univ Nicolae Testemitanu Metoda de tratament al pacientilor cu ciroze hepatice
DE102005025906A1 (de) * 2005-06-06 2006-12-07 Dorian Bevec Therapeutischer Gebrauch aromatischer Guanylhydrazone zur Behandlung von Hepatitis C Virus-verursachten Erkrankungen
DE102005059750A1 (de) * 2005-12-09 2007-06-14 Salama, Zoser Boulis, Dr. Antikrebsmittel umfassend Arsen-Verbindungen
WO2011061454A1 (fr) * 2009-11-20 2011-05-26 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Utilisation d'immunoglobulines polyvalentes pour traiter une cirrhose hepatique alcoolique ou metabolique
MD4317B1 (en) * 2013-09-12 2015-01-31 Gheorghe Anghelici Use of 3-(2,2,2-trimethylhydrazinium)propionate dihydrate for treating patients with advanced liver cirrhosis associated with heart failure

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Jamese J. H., Ziparo V., Jeppsson B., Fischer J. E. Hyperammonaemia, plasma aminoacid imbalance and blood-brain aminoacid transport: a unified theory of portal systemic encephalopathy // Lancet, 1979, v. 2, p. 772-775 *
Дану М., Павлюк Г. Опыт применения Lecitina в комплексной терапии у больных с циррозом печени, осложненным кровотечением из вен пищевода. IX Международный конгресс хирургов-гепатологов России и СНГ., Санкт-Петербург, 2002, р. 74 *

Also Published As

Publication number Publication date
MD20150017A2 (ro) 2016-04-30
MD4458B1 (ro) 2017-01-31

Similar Documents

Publication Publication Date Title
JO3784B1 (ar) الاستخدام المشترك للاجسمام المضادة pd-1 ومضادات m-csf في علاج السرطان
MX2016011862A (es) Inhibidores de c5a para el tratamiento de la neumonia viral.
PH12016502352A1 (en) Pharmaceutical composition
TW201613578A (en) Pharmaceutical combinations
ECSP16084317A (es) Formulaciones farmacéuticas, procesos para la preparación y métodos de uso
MX2017003780A (es) Composicion farmaceutica para tratar colitis ulcerativa.
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
PH12017500617A1 (en) Dosage regimen for pegylated interferon
MD4763B1 (ro) Compoziţie farmaceutică
MX2018006631A (es) Compuesto para uso en la prevencion y tratamiento de enfermedades neurodegenerativas.
MD4458C1 (ro) Utilizarea preparatului Polibiolină în tratamentul bolnavilor cu ciroză hepatică
TW201613600A (en) Piperazinyl derivative reduces HFD-induced accumulation of fat in the liver, therapeutically
MD4317B1 (en) Use of 3-(2,2,2-trimethylhydrazinium)propionate dihydrate for treating patients with advanced liver cirrhosis associated with heart failure
UA95834U (uk) Спосіб лікування гострого ішемічного інсульту
EA201892708A1 (ru) Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе
IN2014DE00822A (ro)
MD4231B1 (ro) Remediu medicamentos pe baza de troxerutin si carbazocrom pentru tratamentul gastropatiilor portale în ciroza hepatica
MD4316C1 (ro) Utilizarea propionatului de 3-(2, 2, 2-trimetilhidraziniu) dihidrat pentru tratamentul gastropatiilor portale la pacienţii cu ciroză hepatică
UA91605U (uk) Спосіб корекції порушень мікроциркуляції в слизовій оболонці шлунка у людей літнього віку
IN2014DE00818A (ro)
PH12014000105A1 (en) Therapeutic methods and compositions for treating diabetes utilizing diterpenoid compounds
MD4232B1 (ro) Remediu medicamentos pe baza de troxerutin si carbazocrom pentru tratamentul cirozei hepatice avansate asociate cu insuficienta cardiaca
UA85352U (ru) Фармацевтический продукт, содержащий налбуфин

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees